Jude Samulski

973 total citations
12 papers, 765 citations indexed

About

Jude Samulski is a scholar working on Molecular Biology, Genetics and Infectious Diseases. According to data from OpenAlex, Jude Samulski has authored 12 papers receiving a total of 765 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Genetics and 2 papers in Infectious Diseases. Recurrent topics in Jude Samulski's work include Virus-based gene therapy research (8 papers), CRISPR and Genetic Engineering (5 papers) and Viral Infectious Diseases and Gene Expression in Insects (3 papers). Jude Samulski is often cited by papers focused on Virus-based gene therapy research (8 papers), CRISPR and Genetic Engineering (5 papers) and Viral Infectious Diseases and Gene Expression in Insects (3 papers). Jude Samulski collaborates with scholars based in United States, India and France. Jude Samulski's co-authors include Joseph E. Rabinowitz, Philippe Moullier, Fabienne Rolling, Yan Chérel, Hervé Conrath, Delphine Briot, Pierre Chenuaud, Nathalie Provost, Michel Weber and Robert F. Schwabe and has published in prestigious journals such as Hepatology, European Heart Journal and Current Opinion in Biotechnology.

In The Last Decade

Jude Samulski

12 papers receiving 737 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jude Samulski United States	9	512	430	118	103	70	12	765
Françoise Bergametti France	19	488 1.0×	156 0.4×	309 2.6×	79 0.8×	130 1.9×	29	1.9k
Grant J. Logan Australia	15	529 1.0×	308 0.7×	62 0.5×	67 0.7×	21 0.3×	37	767
Niema Ibrahim Saudi Arabia	17	411 0.8×	257 0.6×	78 0.7×	97 0.9×	16 0.2×	22	767
Mordechai Bodner United States	13	964 1.9×	684 1.6×	110 0.9×	130 1.3×	20 0.3×	15	1.7k
Tatiana Rokhlina United States	13	688 1.3×	479 1.1×	81 0.7×	114 1.1×	11 0.2×	15	1.3k
Faye A. Eggerding United States	15	395 0.8×	248 0.6×	51 0.4×	119 1.2×	19 0.3×	27	847
Eugene Daniels Canada	15	413 0.8×	91 0.2×	92 0.8×	61 0.6×	50 0.7×	29	919
Jean‐Marie Heslan France	20	305 0.6×	137 0.3×	45 0.4×	113 1.1×	30 0.4×	34	777
Chuanyin Li China	17	509 1.0×	133 0.3×	117 1.0×	68 0.7×	13 0.2×	71	882
Yutaka Negishi Japan	16	233 0.5×	199 0.5×	52 0.4×	99 1.0×	17 0.2×	37	576

Countries citing papers authored by Jude Samulski

Since Specialization

Citations

This map shows the geographic impact of Jude Samulski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jude Samulski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jude Samulski more than expected).

Fields of papers citing papers by Jude Samulski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jude Samulski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jude Samulski. The network helps show where Jude Samulski may publish in the future.

Co-authorship network of co-authors of Jude Samulski

This figure shows the co-authorship network connecting the top 25 collaborators of Jude Samulski. A scholar is included among the top collaborators of Jude Samulski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jude Samulski. Jude Samulski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Henry, Timothy D., Eugene Chung, Lothar Roessig, et al.. (2025). GenePHIT Phase 2 Study Design: A Double Blind, Placebo-controlled Trial To Assess Efficacy, Safety, And Tolerability Of Ab-1002 Gene Therapy In Adults With Heart Failure. Journal of Cardiac Failure. 31(1). 234–234. 2 indexed citations

Henry, Timothy D., Eugene Chung, M.F. Alvisi, et al.. (2024). GenePHIT phase 2 study design: a double blind, placebo-controlled trial to assess efficacy, safety, and tolerability of AB-1002 gene therapy in adults with heart failure. European Heart Journal. 45(Supplement_1). 1 indexed citations

Henry, Timothy D., Eugene Chung, Jay H. Traverse, et al.. (2022). A first-in-human phase 1 clinical gene therapy trial for the treatment of heart failure using a novel rationally designed cardiotropic adeno-associated vector. Journal of Molecular and Cellular Cardiology. 173. S113–S113. 2 indexed citations

Messina, Emily, Jeffrey J. Nienaber, Mani A. Daneshmand, et al.. (2012). Adeno-Associated Viral Vectors Based on Serotype 3b Use Components of the Fibroblast Growth Factor Receptor Signaling Complex for Efficient Transduction. Human Gene Therapy. 23(10). 1031–1042. 8 indexed citations

Kantor, Boris, Hong Ma, Jude Samulski, et al.. (2010). Notable Reduction in Illegitimate Integration Mediated by a PPT-deleted, Nonintegrating Lentiviral Vector. Molecular Therapy. 19(3). 547–556. 50 indexed citations

Birsner, Amy E., Roger W. Chan, Stephen D. Gillies, et al.. (2006). Endostatin therapy reveals a U-shaped curve for antitumor activity. Cancer Gene Therapy. 13(6). 619–627. 50 indexed citations

Weber, Michel, Joseph E. Rabinowitz, Nathalie Provost, et al.. (2003). Recombinant adeno-associated virus serotype 4 mediates unique and exclusive long-term transduction of retinal pigmented epithelium in rat, dog, and nonhuman primate after subretinal delivery. Molecular Therapy. 7(6). 774–781. 158 indexed citations

Lehmann, Thorsten, Michael D. Wheeler, Matthias Froh, et al.. (2003). EFFECTS OF THREE SUPEROXIDE DISMUTASE GENES DELIVERED WITH AN ADENOVIRUS ON GRAFT FUNCTION AFTER TRANSPLANTATION OF FATTY LIVERS IN THE RAT1. Transplantation. 76(1). 28–37. 49 indexed citations

Janson, Christopher G., Scott McPhee, Larissa T. Bilaniuk, et al.. (2002). Gene Therapy of Canavan Disease: AAV-2 Vector for Neurosurgical Delivery of Aspartoacylase Gene ( ASPA ) to the Human Brain. Human Gene Therapy. 13(11). 1391–1412. 185 indexed citations

10.

Lehmann, Thorsten, Michael D. Wheeler, Robert F. Schwabe, et al.. (2000). Gene Delivery of Cu/Zn–Superoxide Dismutase Improves Graft Function After Transplantation of Fatty Livers in the Rat. Hepatology. 32(6). 1255–1264. 68 indexed citations

11.

Rabinowitz, Joseph E. & Jude Samulski. (1998). Adeno-associated virus expression systems for gene transfer. Current Opinion in Biotechnology. 9(5). 470–475. 112 indexed citations

12.

Ross, Gail, Robert P. Erickson, Arno G. Motulsky, et al.. (1996). Gene Therapy in the United States: A Five-Year Status Report. Human Gene Therapy. 7(14). 1781–1790. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact